Kenneth Wheeler Counselor Medicare: Not Enrolled in Medicare Practice Location: Rhp, Inc., 140 Redwood Lane/pinehills Subdivision, Marehead, KY 40351 Phone: 606-784-2790 |
News Archive
Integrated Medical Systems, Inc., a medical technology systems integrator transforming critical care, announced that it has received $1.1 million in funding from the U.S. Department of Defense for additional enhancements of the company's MedEx 1000(TM) "suitcase" intensive care unit (ICU).
Smoking at least ten cigarettes a day is linked to a higher risk of psychoses compared to non-smoking young people. The risk is also raised if the smoking starts before the age of 13. This has been shown in a study led by Academy Research Fellow, Professor Jouko Miettunen. The results were recently published in the journal Acta Psychiatrica Scandinavica.
A delayed neurological response to processing the written word could be an indicator that a patient with mild memory problems is at an increased risk of developing Alzheimer's disease, research led by the University of Birmingham has discovered.
Melanoma is one of the less common types of skin cancer but it accounts for the majority of the skin cancer deaths (about 75 percent).The five-year survival rate for early stage melanoma is very high (98 percent), but the rate drops precipitously if the cancer is detected late or there is recurrence.So a great deal rides on the accuracy of the initial surgery, where the goal is to remove as little tissue as possible while obtaining "clean margins" all around the tumor.So far no imaging technique has been up to the task of defining the melanoma's boundaries accurately enough to guide surgery.Instead surgeons tend to cut well beyond the visible margins of the lesion in order to be certain they remove all the malignant tissue.Two scientists at Washington University in St. Louis have developed technologies that together promise to solve this difficult problem.
Janssen Biotech, Inc., one of the Janssen pharmaceutical companies of Johnson & Johnson announced today an exclusive, worldwide license agreement with Alligator Bioscience AB for ADC-1013, an immuno-oncology agent currently in Phase 1 clinical studies.
› Verified 8 days ago